ReviewCurrent pharmaceutical design2024

Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics.

Ramin Raoufinia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.